Journal article
Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK
CJ Thomas, DCH Ng, N Patsikatheodorou, Y Limengka, MWK Lee, IA Darby, OL Woodman, CN May
European Journal of Pharmacology | Published : 2011
Abstract
Oxidative stress, activation of intracellular protein kinases and cardiomyocyte apoptosis are known mediators of cardiac ischaemia/reperfusion injury. The sites at which NP202, a novel water soluble pro-drug of 3′,4′-dihydroxyflavonol (DiOHF), acts in this cascade to cause cardioprotection are unknown. In this study we examined the ability of NP202 to reduce infarct size after a prolonged period of ischaemia and reperfusion. In addition, we tested whether NP202 inhibits pro-apoptotic signalling, apoptosis and inflammation following myocardial ischaemia and reperfusion. Sheep were anaesthetised, the heart exposed and the 2nd branch of the left anterior descending coronary artery isolated. The..
View full abstractRelated Projects (1)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by a grant-in-aid from the National Heart Foundation of Australia (G 08M 3761). CNM was supported by a Research Fellowship from NHMRC, Australia (566819). DN is supported by a NHFA/NHMRC Fellowship (404126).